Log In
Company Data

Outlook Therapeutics Inc.

Healthcare
Biotechnology
Advanced Market Data
Ticker
OTLK
Current Price
$1.08 1.89%
Market Cap
$244.2M
Price Target
Refer to Report
Volume
240.5K
52wk Range
$0.6839 - $2.12
Advanced Market Data

Overview

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Other Considerations

Baudax Bio Inc.
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
‌
Baudax Bio Inc.
Baudax Bio Inc.
BXRX (Nasdaq)
$0.1488
$0.14(6.29%)
3.0M
685.1K
$0.131 - $14.7
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Imugene Ltd.
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
‌
Imugene Ltd.
Imugene Ltd.
IUGNF (OTO)
$0.13
$0.15(-13.33%)
828.1M
10.7K
$0.0837 - $0.404
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
PsyBio Therapeutics
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
‌
PsyBio Therapeutics
PsyBio Therapeutics
PSYBF (OTO)
$0.03355
$0.04(-12.86%)
3.7M
2.4K
$0.029 - $0.3192
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Axcella Therapeutics
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
‌
Axcella Therapeutics
Axcella Therapeutics
AXLA (Nasdaq)
$0.87
$0.83(4.69%)
31.7M
32.4K
$0.7006 - $3.04
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Psybio Therapeutics Corp.
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
‌
Psybio Therapeutics Corp.
Psybio Therapeutics Corp.
PSYB:CA (CDX)
$0.055
6.1M
97.7K
$0.04 - $0.375
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In